Sartorius Aktiengesellschaft Logo

Sartorius Aktiengesellschaft

0NIQ.L

(0.0)
Stock Price

194,20 EUR

8.27% ROA

10.13% ROE

49.88x PER

Market Cap.

19.938.315.896,00 EUR

237.98% DER

0.56% Yield

6.04% NPM

Sartorius Aktiengesellschaft Stock Analysis

Sartorius Aktiengesellschaft Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Sartorius Aktiengesellschaft Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Sartorius Aktiengesellschaft Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Sartorius Aktiengesellschaft Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Sartorius Aktiengesellschaft Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Sartorius Aktiengesellschaft Revenue
Year Revenue Growth
2012 845.710.000
2013 791.559.000 -6.84%
2014 891.168.000 11.18%
2015 1.114.752.000 20.06%
2016 1.300.296.000 14.27%
2017 1.404.569.000 7.42%
2018 1.566.033.000 10.31%
2019 1.826.966.000 14.28%
2020 2.335.657.000 21.78%
2021 3.449.200.000 32.28%
2022 4.174.700.000 17.38%
2023 3.242.800.000 -28.74%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Sartorius Aktiengesellschaft Research and Development Expenses
Year Research and Development Expenses Growth
2012 54.040.000
2013 47.710.000 -13.27%
2014 53.668.000 11.1%
2015 59.134.000 9.24%
2016 68.860.000 14.12%
2017 77.714.000 11.39%
2018 86.466.000 10.12%
2019 110.412.000 21.69%
2020 130.889.999 15.65%
2021 165.100.000 20.72%
2022 211.600.000 21.98%
2023 156.000.000 -35.64%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Sartorius Aktiengesellschaft General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 49.846.000
2013 49.688.000 -0.32%
2014 58.280.000 14.74%
2015 65.736.000 11.34%
2016 74.713.000 12.02%
2017 83.296.000 10.3%
2018 94.235.000 11.61%
2019 107.206.000 12.1%
2020 125.940.000 14.88%
2021 165.000.000 23.67%
2022 200.500.000 17.71%
2023 205.600.000 2.48%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Sartorius Aktiengesellschaft EBITDA
Year EBITDA Growth
2012 156.422.000
2013 154.628.000 -1.16%
2014 173.309.000 10.78%
2015 262.642.999 34.01%
2016 311.194.000 15.6%
2017 350.700.600 11.27%
2018 404.369.000 13.27%
2019 473.551.000 14.61%
2020 646.782.000 26.78%
2021 1.113.200.000 41.9%
2022 1.397.100.000 20.32%
2023 726.000.000 -92.44%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Sartorius Aktiengesellschaft Gross Profit
Year Gross Profit Growth
2012 415.918.000
2013 384.602.000 -8.14%
2014 422.763.000 9.03%
2015 551.747.000 23.38%
2016 631.795.000 12.67%
2017 706.843.000 10.62%
2018 803.603.000 12.04%
2019 941.099.000 14.61%
2020 1.206.394.000 21.99%
2021 1.838.900.000 34.4%
2022 2.196.400.000 16.28%
2023 1.439.600.000 -52.57%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Sartorius Aktiengesellschaft Net Profit
Year Net Profit Growth
2012 48.510.000
2013 47.886.000 -1.3%
2014 43.964.000 -8.92%
2015 85.461.000 48.56%
2016 102.932.000 16.97%
2017 114.730.000 10.28%
2018 141.342.000 18.83%
2019 156.692.000 9.8%
2020 210.095.000 25.42%
2021 318.900.000 34.12%
2022 678.100.000 52.97%
2023 34.400.000 -1871.22%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Sartorius Aktiengesellschaft Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 1
2013 1 0%
2014 1 0%
2015 1 100%
2016 2 0%
2017 2 0%
2018 2 50%
2019 2 0%
2020 3 33.33%
2021 5 25%
2022 10 55.56%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Sartorius Aktiengesellschaft Free Cashflow
Year Free Cashflow Growth
2012 -9.789.000
2013 47.254.000 120.72%
2014 43.543.999 -8.52%
2015 13.926.000 -212.68%
2016 21.657.000 35.7%
2017 9.405.000 -130.27%
2018 11.340.000 17.06%
2019 151.618.000 92.52%
2020 271.271.000 44.11%
2021 466.000.000 41.79%
2022 211.600.000 -120.23%
2023 46.000.000 -360%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Sartorius Aktiengesellschaft Operating Cashflow
Year Operating Cashflow Growth
2012 53.163.000
2013 103.260.000 48.52%
2014 129.687.999 20.38%
2015 125.362.000 -3.45%
2016 170.421.000 26.44%
2017 206.509.000 17.48%
2018 244.524.000 15.55%
2019 377.186.000 35.17%
2020 511.525.000 26.26%
2021 873.200.000 41.42%
2022 734.200.000 -18.93%
2023 180.000.000 -307.89%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Sartorius Aktiengesellschaft Capital Expenditure
Year Capital Expenditure Growth
2012 62.952.000
2013 56.006.000 -12.4%
2014 86.144.000 34.99%
2015 111.436.000 22.7%
2016 148.764.000 25.09%
2017 197.104.000 24.53%
2018 233.184.000 15.47%
2019 225.568.000 -3.38%
2020 240.254.000 6.11%
2021 407.200.000 41%
2022 522.600.000 22.08%
2023 134.000.000 -290%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Sartorius Aktiengesellschaft Equity
Year Equity Growth
2012 404.431.000
2013 450.250.000 10.18%
2014 497.663.000 9.53%
2015 644.750.999 22.81%
2016 736.802.000 12.49%
2017 806.559.000 8.65%
2018 973.389.000 17.14%
2019 1.093.175.999 10.96%
2020 1.380.295.000 20.8%
2021 1.720.200.000 19.76%
2022 2.658.800.000 35.3%
2023 2.744.499.999 3.12%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Sartorius Aktiengesellschaft Assets
Year Assets Growth
2012 1.070.891.000
2013 1.181.320.000 9.35%
2014 1.273.031.000 7.2%
2015 1.437.235.000 11.42%
2016 1.752.986.000 18.01%
2017 2.297.720.000 23.71%
2018 2.526.875.000 9.07%
2019 2.868.547.000 11.91%
2020 4.484.744.000 36.04%
2021 5.697.900.000 21.29%
2022 6.977.700.000 18.34%
2023 9.960.700.000 29.95%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Sartorius Aktiengesellschaft Liabilities
Year Liabilities Growth
2012 666.460.000
2013 731.070.000 8.84%
2014 775.368.000 5.71%
2015 792.484.000 2.16%
2016 1.016.184.000 22.01%
2017 1.491.161.000 31.85%
2018 1.553.486.000 4.01%
2019 1.775.371.000 12.5%
2020 3.104.449.000 42.81%
2021 3.977.700.000 21.95%
2022 4.318.900.000 7.9%
2023 7.216.200.000 40.15%

Sartorius Aktiengesellschaft Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
52.73
Net Income per Share
5.1
Price to Earning Ratio
49.88x
Price To Sales Ratio
5.53x
POCF Ratio
21.05
PFCF Ratio
90.01
Price to Book Ratio
8.42
EV to Sales
5.45
EV Over EBITDA
19.46
EV to Operating CashFlow
23.75
EV to FreeCashFlow
88.69
Earnings Yield
0.02
FreeCashFlow Yield
0.01
Market Cap
19,94 Bil.
Enterprise Value
19,64 Bil.
Graham Number
58.9
Graham NetNet
-88.59

Income Statement Metrics

Net Income per Share
5.1
Income Quality
2.37
ROE
0.17
Return On Assets
0.02
Return On Capital Employed
0.08
Net Income per EBT
0.53
EBT Per Ebit
0.58
Ebit per Revenue
0.2
Effective Tax Rate
0.25

Margins

Sales, General, & Administrative to Revenue
0.05
Research & Developement to Revenue
0.06
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.46
Operating Profit Margin
0.2
Pretax Profit Margin
0.11
Net Profit Margin
0.06

Dividends

Dividend Yield
0.01
Dividend Yield %
0.56
Payout Ratio
0.28
Dividend Per Share
1.43

Operating Metrics

Operating Cashflow per Share
12.09
Free CashFlow per Share
3.24
Capex to Operating CashFlow
-0.73
Capex to Revenue
-0.17
Capex to Depreciation
-1.96
Return on Invested Capital
0.08
Return on Tangible Assets
0.08
Days Sales Outstanding
38.32
Days Payables Outstanding
91.49
Days of Inventory on Hand
233.66
Receivables Turnover
9.52
Payables Turnover
3.99
Inventory Turnover
1.56
Capex per Share
-8.85

Balance Sheet

Cash per Share
4,30
Book Value per Share
30,22
Tangible Book Value per Share
-43.77
Shareholders Equity per Share
30.22
Interest Debt per Share
71.91
Debt to Equity
2.38
Debt to Assets
0.49
Net Debt to EBITDA
-0.29
Current Ratio
1.49
Tangible Asset Value
-2,99 Bil.
Net Current Asset Value
-5,20 Bil.
Invested Capital
2.38
Working Capital
0,66 Bil.
Intangibles to Total Assets
0.58
Average Receivables
0,39 Bil.
Average Payables
0,47 Bil.
Average Inventory
1173900000
Debt to Market Cap
0.25

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Sartorius Aktiengesellschaft Dividends
Year Dividends Growth
2011 1
2012 1 0%
2013 1 0%
2014 1 100%
2015 1 0%
2016 2 0%
2017 0 0%
2023 1 100%

Sartorius Aktiengesellschaft Profile

About Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

CEO
Dr. Joachim Kreuzburg
Employee
14.614
Address
Otto-Brenner-Strasse 20
Göttingen, 37079

Sartorius Aktiengesellschaft Executives & BODs

Sartorius Aktiengesellschaft Executives & BODs
# Name Age
1 Dr. Joachim Kreuzburg
Chairman of Executive Board, Chief Executive Officer & Interim Chief Financial Officer
70
2 Ms. Petra Muller
Head of Investor Relations
70
3 Dr. Theo Thijssen
President of Environmental Technology Division
70
4 Ms. Petra Kirchhoff
Head of Corporate Communications & Investor Relations and Member of Supervisory Board
70
5 Ms. Patricia Spannagel
Head of Quality Assurance - Mechatronics Division Goettingen
70
6 Mr. Maurice Phelan
President of Sartorius North America
70
7 Ralf Mohrschladt
Physicist & Head of Supply Chain Management - Germany
70
8 Dr. Rene Faber
Head of Bioprocess Solutions Division & Member of Executive Board
70
9 Dr. Alexandra Gatzemeyer
Head of the Lab Products & Services Division and Member of Executive Board
70

Sartorius Aktiengesellschaft Competitors